Vani Pathuri holds a academic foundation in healthcare and business, beginning with a nursing degree from Owaisi College of ...

Mirati Therapeutics is the subject of takeover speculation in the biopharma sector once again, as it waits for the FDA's decision on its KRAS inhibitor adagrasib in non-small cell lung cancer (NSCLC).

After months of speculation about a possible takeover of Mirati Therapeutics, Bristol-Myers Squibb has reached a deal to buy the company and its KRAS inhibitor Krazati in a deal valued at up to $5 ...

Review Denali Therapeutics Inc (DNLI:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

United Therapeutics Corporation (NASDAQ:UTHR) is one of the most undervalued US stocks according to analysts. On June 24, ...

Find the latest Kura Oncology, Inc. (KURA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Dr. Mir Hashim is a Chief Scientific Officer at Rani Therapeutics Holdings, Inc., a Vice President-Research & Development at InCube Labs LLC and a Chief Scientific Officer & Director at Rani ...

Get the latest news and real-time alerts from Bristol-Myers Squibb Company (BMY) stock at Seeking Alpha.